Posted on May 20, 2015 in Biographies
Written by: David B. Honig
Hall, Render, Killian, Heath & Lyman, LLP
3015 Carrington Mill Boulevard
Morrisville, NC 27560
Amy Garrigues is a Shareholder and the Managing Partner of Hall Render’s Raleigh office and concentrates her practice exclusively on health law. She primarily represents academic medical centers, hospitals and health systems across the country. Amy regularly advises clients on regulatory and compliance issues; fraud and abuse laws, including Stark and Anti-Kickback; federal False Claims Act lawsuits and investigations; health care transactions; EMTALA; HIPAA; federal provider-based regulations; federal health care program requirements; Medicare and Medicaid reimbursement issues; Recovery Audit Contractor appeals; peer review laws; corporate practice of medicine laws; and hospital licensure and certification laws. Prior to law school, Amy worked as a health care strategy consultant with a global consulting firm. She was named as an Associate to Watch in the 2014 Chambers USA Healthcare – North Carolina rankings and a Rising Star by North Carolina Super Lawyers in 2010.
- Harvard University, A.B., magna cum laude, Phi Beta Kappa – 2001
- Harvard Law School, J.D. – 2006
Admitted to Bar
- North Carolina – 2006
- U.S. District Court for the Eastern District of North Carolina
- U.S. District Court for the Fourth Circuit
- American Health Lawyers Association
- American Bar Association, Health Law Section
- North Carolina Bar, Health Law Section
- North Carolina Society of Health Care Attorneys
Representative FCA cases
United States ex. rel. Kendall Suh, et al. v. HCA – The Healthcare Co. Represented national hospital system in resolution of False Claims Act lawsuit in Eastern District of North Carolina involving allegations of improper billing of physician assistants and in subsequent resolution of related FCA retaliation claim by former emergency room physician.
United States, ex rel. John D’Alessio, M.D. et al. v. Vanderbilt University. A major academic medical center in involved in ongoing FCA litigation in the Middle District of Tennessee involving allegations of lack of teaching physician presence in connection with overlapping surgeries, medical direction of anesthesia services, and procedures performed in an Intensive Care Unit setting; lawsuit was unsealed in September 2013 after government decided not to intervene.
United States, State of Florida, ex rel. Mariela Barnes, v. Dr. David Spellberg, 21st Century Oncology and Naples Urology Associates. Represented an international radiation therapy company to resolve an FCA lawsuit involving allegations of lack of medical necessity involving Fluorescence in Situ (FISH) tests and related inquiry into Stark compensation practices, and related entry into Corporate Integrity Agreement.
United States ex rel. Hanks v. Amgen, Inc. Represented a medical oncology company in getting dismissed from an FCA lawsuit in Eastern District of New York.
(Sealed) v. (Sealed). Represented a large hospital system in connection with resolution of FCA lawsuit involving allegations of improper ambulance billing and related entry into Corporate Integrity Agreement.
(Sealed) v. (Sealed). Represented an academic medical center in connection with False Claims Act lawsuit involving allegations that its employed physician received improper benefits from a medical device company.
Represented a hospital in resolution of government inquiry originating from Southern District of New York and related FCA release in connection with allegations regarding its zero to one day stay billing practices and kyphoplasty procedures.
Tuomey Revisited: Key Takeaways for Health Care Attorneys, Prognosis Newsletter, North Carolina Bar Association, Health Law Section, Vol. 30, No. 1, August 2013.
Relationships Between Physicians and Hospitals, BNA – The Health Care Compliance Guide, Issue 142, Chapter 2210, April 16, 2012.
Stark’s ‘Bright Line’ Gets More Complicated with Proposed Rules, Prognosis Newsletter, North Carolina Bar Association, Health Law Section, North Carolina Society of Health Care Attorneys, May 2008.
The Eleventh Circuit Holds That Agreements in Which Pharmaceutical Companies Pay Generic Companies Not to Compete May Be Valid, Journal of Law, Medicine, and Ethics, Spring 2004.